Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
perillyl alcohol (1 trial)
san007 (1 trial)
san021 (2 trials)
ad-sig-hmuc-1/ecdcd40l vaccine (1 trial)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Eczema (Phase 2)
Glioblastoma (Phase 2)
Lung Neoplasms (Phase 1)
Psoriasis (Phase 2)
Trials (5 total)
Trial APIs (4 total)